Article thumbnail

The mind-body-microbial continuum

By Antonio Gonzalez, Jesse Stombaugh, Catherine Lozupone, Peter J. Turnbaugh, Jeffrey I. Gordon and Rob Knight

Abstract

Our understanding of the vast collection of microbes that live on and inside us (microbiota) and their collective genes (microbiome) has been revolutionized by culture-independent “metagenomic” techniques and DNA sequencing technologies. Most of our microbes live in our gut, where they function as a metabolic organ and provide attributes not encoded in our human genome. Metagenomic studies are revealing shared and distinctive features of microbial communities inhabiting different humans. A central question in psychiatry is the relative role of genes and environment in shaping behavior. The human microbiome serves as the interface between our genes and our history of environmental exposures; explorations of our microbiomes thus offer the possibility of providing new insights into our neurodevelopment and our behavioral phenotypes by affecting complex processes such as inter- and intra personal variations in cognition, personality, mood, sleep, and eating behavior, and perhaps even a variety of neuropsychiatric diseases ranging from affective disorders to autism. Better understanding of microbiome-encoded pathways for xenobiotic metabolism also has important implications for improving the efficacy of pharmacologic interventions with neuromodulator agents

Topics: Translational Research
Publisher: Les Laboratoires Servier
OAI identifier: oai:pubmedcentral.nih.gov:3139398
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A core gut microbiome in obese and lean twins.
  2. A human gut microbial gene catalogue established by metagenomic sequencing.
  3. A randomised, controlled study of dietary intervention in autistic syndromes.
  4. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.
  5. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their firstdegree relatives.
  6. Amantadine reduces mania in borna disease virus-infected non-psychotic bipolar patients.
  7. An obesity-associated gut microbiome with increased capacity for energy harvest.
  8. and transcriptional variation in the deeply sequenced gut microbiomes of identical twins.
  9. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry.
  10. (1999). Antiretroviral antibodies: implications for schizophrenia, schizophrenia spectrum disorders, and bipolar disorder. Biol Psychiatry.
  11. Attentiondeficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides.
  12. (1996). Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives.
  13. Bacterial community variation in human body habitats across space and time.
  14. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors.
  15. Cognitive and emotional changes in neurobrucellosis.
  16. Commensal bacteria play a role in mating preference of Drosophila melanogaster.
  17. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women.
  18. (2005). Decreased level of novelty seeking in blood donors infected with Toxoplasma. Neuro Endocrinol Lett.
  19. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.
  20. Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria.
  21. Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatr Serv.
  22. Dietary sensitivities and ADHD symptoms: thirty-five years of research. Clin Pediatr (Phila).
  23. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children.
  24. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions.
  25. Diversity of the human intestinal microbial flora.
  26. Emerging highthroughput approaches to analyze bioremediation of sites contaminated with hazardous and/or recalcitrant wastes.
  27. Environmental genomics: exploring the unmined richness of microbes to degrade xenobiotics.
  28. Factors affecting the enterohepatic circulation of oral contraceptive steroids.
  29. Fatal attraction in rats infected with Toxoplasma gondii.
  30. (2002). Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis.
  31. Genetics of autism spectrum disorder.
  32. High-fat diet determines the composition of the murine gut microbiome independently of obesity.
  33. Humanized animal models of the microbiome. J Anim Sci.
  34. (2008). Is mate choice in humans MHC-dependent? PLoS Genet.
  35. (2006). John's wort attenuates irinotecaninduced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis. Toxicol Appl Pharmacol.
  36. Leptospirosis presenting with mania and psychosis: four consecutive cases seen in a military hospital in Turkey.
  37. Mapping autism risk loci using genetic linkage and chromosomal rearrangements.
  38. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.
  39. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.
  40. (1978). Metabolism of drugs and other foreign compounds by intestinal microorganisms. World Rev Nutr Diet.
  41. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol.
  42. Microbes and Health Sackler Colloquium: Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.
  43. Microbes and Health Sackler Colloquium: Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A. In press.
  44. Microbial ecology: human gut microbes associated with obesity.
  45. (1990). Murine scent mark microbial communities are genetically determined.
  46. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.
  47. Neuroinflammation and brain infections: Historical context and current perspectives. Brain Res Rev.
  48. noncytolytic infection of neurons by Borna disease virus interferes with ERK 1/2 signaling and abrogates BDNF-induced synaptogenesis.
  49. Obesity alters gut microbial ecology.
  50. Pharmacogenetics of irinotecan metabolism and transport: an update. Toxicol In
  51. (2006). Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab Rev.
  52. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.
  53. (2002). Psychiatric complications in human immunodeficiency virus infection. J Neurovirol.
  54. Psychiatric issues in the management of patients with multidrug-resistant tuberculosis.
  55. Real-time PCR quantitation of clostridia in feces of autistic children.
  56. (2011). Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil.
  57. (2009). Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc Natl Acad Sci
  58. RNA from Borna disease virus in patients with schizophrenia, schizoaffective patients, and in their biological relatives.
  59. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.
  60. Short-term benefit from oral vancomycin treatment of regressive-onset autism.
  61. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen. Cancer Chemother Pharmacol.
  62. Successful treatment of bipolar disorder II and ADHD with a micronutrient formula: a case study.
  63. The gastrointestinal microbiota as a site for the biotransformation of drugs.
  64. The gut microbiota as an environmental factor that regulates fat storage.
  65. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction.
  66. (2008). The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol.
  67. (2003). The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumours. Oncol Rep.
  68. The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat.
  69. The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders.
  70. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls.
  71. Variation in gut microbiota strongly influences individual rodent phenotypes. Toxicol Sci.